The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Label-free and automated approach to rapidly classify microsatellite instability (MSI) in early colon cancer (CC) analyzing the AIO ColoPredictPlus 2.0 (CPP) registry trial.
 
Stephanie Schörner
No Relationships to Disclose
 
Frederik Großerueschkamp
No Relationships to Disclose
 
Anna-Lena Kraeft
No Relationships to Disclose
 
David Schuhmacher
No Relationships to Disclose
 
Carlo Willy Sternemann
No Relationships to Disclose
 
Inke Sabine Feder
No Relationships to Disclose
 
Sarah Wisser
No Relationships to Disclose
 
Celine Lugnier
Honoraria - Celgene; Taiho Oncology
 
Jens Christmann
Consulting or Advisory Role - AstraZeneca
 
Vera Heuer
No Relationships to Disclose
 
Christian Teschendorf
No Relationships to Disclose
 
Lothar Mueller
Honoraria - Roche
 
Axel Mosig
No Relationships to Disclose
 
Dirk Arnold
Employment - Asklepios Kliniken
Honoraria - Amgen; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb; Ipsen; Merck Serono; Merck Sharp and Dome; Pierre Fabre; Roche/Genentech; SERVIER
Consulting or Advisory Role - AstraZeneca; Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Terumo
Research Funding - Oncolytics (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Boston Scientific
(OPTIONAL) Uncompensated Relationships - ESMO; ESMO Open; European Organisation for Research and Treatment of Cancer (EORTC); German Cancer Society; German Society for Hematology and Medical Oncology
 
Andrea Tannapfel
Honoraria - Amgen; Falk Foundation; Med.Update; Merck; Pfizer
 
Klaus Gerwert
Employment - betaSENSE
Leadership - betaSENSE
Stock and Other Ownership Interests - betaSENSE
Consulting or Advisory Role - Biogen
Patents, Royalties, Other Intellectual Property - betaSENSE
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Bristol-Myers Squibb; MCI Group; Merck Serono; MSD; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); BioNTech (Inst); Celgene (Inst); ERYTECH Pharma (Inst); Ipsen (Inst); Lilly (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Roche